Rochester, NY 8/25/2009 10:51:28 PM
GlaxoSmithKline plc ADR GSK, Penile Cancer goes worst to Virus
GlaxoSmithKline plc ADR
Researchers said all cases about half of penile cancer are linked to a sexually transmitted virus that causes cervical cancer in women and might be prevented with vaccines from Merck & Co. and GlaxoSmithKline Plc.
A review of 31 studies involving 1,466 men with penile cancer found the human papillomavirus was present 46.9 percent of the time, Journal of Clinical Pathology reported. Each year about 26,300 men develop penile cancer. It accounts for less than 1 percent of cancers in European and North American men, and up to 10 percent of tumors in men from Africa and Asia, studies show. The review was funded through Spanish public grants. De Sanjose has received research grants from Merck, its partner Sanofi-Aventis SA and Glaxo. The companies had no role in preparing, analyzing or interpreting the research, the authors of the review said.
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
